[Toric-ICL shows better predictability and efficacy than FS-LASIK for myopia correction in patients with moderate to high myopia and astigmatism].
Although the patients included in Toric-ICL group had higher myopia and astigmatism, Toric-ICL still showed better predictability and efficacy for astigmatic correction in Toric-ICL group. Toric-ICL is an effective and safe equivalent of FS-LASIK for correcting moderate myopia but can be more advantageous for correcting high myopia with astigmatism.
Authors
- Changhuei Yang (ORCID: https://orcid.org/0000-0001-8791-0354)
- Yi Wu (ORCID: https://orcid.org/0000-0002-6163-6737)
- D. Tan (ORCID: https://orcid.org/0000-0003-0180-6666)
- Peng Lei (ORCID: https://orcid.org/0000-0001-5652-1962)
- Wenxiong Liao (ORCID: https://orcid.org/0000-0002-9432-9426)
- Sijing Liu
- Hongyang Li (ORCID: https://orcid.org/0000-0002-9014-7502)
- Yanying Li (ORCID: https://orcid.org/0000-0003-3786-8148)
- Liping Xue (ORCID: https://orcid.org/0000-0002-8133-658X)
- Mei-Lan Chen (ORCID: https://orcid.org/0000-0002-0461-1066)
Institutions
- Guangdong Provincial People's Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-06-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2025.06.01
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00